• Je něco špatně v tomto záznamu ?

Antiviral potentials of Lactobacillus plantarum, Lactobacillus amylovorus, and Enterococcus hirae against selected Enterovirus

AA. Sunmola, OO. Ogbole, TOC. Faleye, A. Adetoye, JA. Adeniji, FA. Ayeni,

. 2019 ; 64 (2) : 257-264. [pub] 20180929

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc19015085

Enteroviruses have been associated with a host of clinical presentations including acute flaccid paralysis (AFP). The site of primary replication for most enteroviruses is the gastrointestinal tract (GIT) and lactic acid bacteria (LAB) may confer protection in the GIT against them. This study therefore investigates the antiviral potential of some selected lactic acid bacteria against enterovirus isolates recovered from AFP cases. The antiviral activities of Lactobacillus plantarum, Lactobacillus amylovorus, and Enterococcus hirae in broth culture, their cell-free supernatant (CFS), and bacterial cell pellets were assayed against Echovirus 7 (E7), E13, and E19 in a pre- and post-treatment approach using cytopathic effect (CPE) and cell viability (MTT) assay. The tested Lactobacillus plantarum, Lactobacillus amylovorus, and Enterococcus hirae strains have good antiviral properties against E7 and E19 but not against E13. Lactobacillus amylovorus AA099 shows the highest activity against E19. The pre-treatment approach displays better antiviral activities compared to post-treatment approach. The LAB in broth suspension have better antiviral activities than their corresponding CFS and bacterial pellet. Lactic acid bacteria used in this study have the potential as antiviral agents.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19015085
003      
CZ-PrNML
005      
20190425081816.0
007      
ta
008      
190423s2019 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1007/s12223-018-0648-6 $2 doi
035    __
$a (PubMed)30267215
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Sunmola, Abidemi Anota $u Department of Pharmaceutical Microbiology, Faculty of Pharmacy, University of Ibadan, Ibadan, Oyo State, Nigeria.
245    10
$a Antiviral potentials of Lactobacillus plantarum, Lactobacillus amylovorus, and Enterococcus hirae against selected Enterovirus / $c AA. Sunmola, OO. Ogbole, TOC. Faleye, A. Adetoye, JA. Adeniji, FA. Ayeni,
520    9_
$a Enteroviruses have been associated with a host of clinical presentations including acute flaccid paralysis (AFP). The site of primary replication for most enteroviruses is the gastrointestinal tract (GIT) and lactic acid bacteria (LAB) may confer protection in the GIT against them. This study therefore investigates the antiviral potential of some selected lactic acid bacteria against enterovirus isolates recovered from AFP cases. The antiviral activities of Lactobacillus plantarum, Lactobacillus amylovorus, and Enterococcus hirae in broth culture, their cell-free supernatant (CFS), and bacterial cell pellets were assayed against Echovirus 7 (E7), E13, and E19 in a pre- and post-treatment approach using cytopathic effect (CPE) and cell viability (MTT) assay. The tested Lactobacillus plantarum, Lactobacillus amylovorus, and Enterococcus hirae strains have good antiviral properties against E7 and E19 but not against E13. Lactobacillus amylovorus AA099 shows the highest activity against E19. The pre-treatment approach displays better antiviral activities compared to post-treatment approach. The LAB in broth suspension have better antiviral activities than their corresponding CFS and bacterial pellet. Lactic acid bacteria used in this study have the potential as antiviral agents.
650    _2
$a antivirové látky $x farmakologie $7 D000998
650    _2
$a nádorové buněčné linie $7 D045744
650    _2
$a viabilita buněk $7 D002470
650    _2
$a Enterococcus hirae $x fyziologie $7 D000070076
650    _2
$a Enterovirus $x klasifikace $x účinky léků $7 D004770
650    _2
$a enterovirové infekce $x prevence a kontrola $x virologie $7 D004769
650    _2
$a lidé $7 D006801
650    _2
$a Lactobacillales $x fyziologie $7 D056546
650    _2
$a Lactobacillus acidophilus $x fyziologie $7 D007779
650    _2
$a Lactobacillus plantarum $x fyziologie $7 D048191
650    _2
$a probiotika $x farmakologie $7 D019936
650    _2
$a druhová specificita $7 D013045
655    _2
$a časopisecké články $7 D016428
700    1_
$a Ogbole, Omonike O $u Department of Pharmacognosy, Faculty of Pharmacy, University of Ibadan, Ibadan, Oyo State, Nigeria. nikeoa@yahoo.com.
700    1_
$a Faleye, Temitope O C $u Department of Virology, University College Hospital, University of Ibadan, Ibadan, Oyo State, Nigeria.
700    1_
$a Adetoye, Adewale $u Department of Pharmaceutical Microbiology, Faculty of Pharmacy, University of Ibadan, Ibadan, Oyo State, Nigeria.
700    1_
$a Adeniji, Johnson A $u Department of Virology, University College Hospital, University of Ibadan, Ibadan, Oyo State, Nigeria.
700    1_
$a Ayeni, Funmilola A $u Department of Pharmaceutical Microbiology, Faculty of Pharmacy, University of Ibadan, Ibadan, Oyo State, Nigeria. funmiyeni@yahoo.co.uk.
773    0_
$w MED00011005 $t Folia microbiologica $x 1874-9356 $g Roč. 64, č. 2 (2019), s. 257-264
856    41
$u https://pubmed.ncbi.nlm.nih.gov/30267215 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20190423 $b ABA008
991    __
$a 20190425081855 $b ABA008
999    __
$a ok $b bmc $g 1398212 $s 1053484
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 64 $c 2 $d 257-264 $e 20180929 $i 1874-9356 $m Folia microbiologica $n Folia microbiol. (Prague) $x MED00011005
LZP    __
$a Pubmed-20190423

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace